sputum cytology
sputum cytology is an intervention with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Diagnostic Value of Sputum Cytology in Asthma-COPD Overlap
Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer
INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
Clinical Trials (7)
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Diagnostic Value of Sputum Cytology in Asthma-COPD Overlap
Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer
INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer
Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer
All 7 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 7